Table 2.
Meta-analysis of published literature, addressing mortality trends in osteoarthritis patients.
| # | PMID | N | HR | # | PMID | N | HR |
|---|---|---|---|---|---|---|---|
| Meta-analysis of published literature | |||||||
| 1 | 30169829[d] | 5.2 × 104 | 1.3/1, K-RKOA | 18 | 20416065 | 2163 | 0.92 HRE |
| 2 | 29588472*[sec] | 809 | 0.76/1.1 HRE/KRE | 19 | 17540743 | 6.4 × 104 | 0.77 HRE, KRE < 12 years follow up |
| 3 | 28754502 | 601 | 1.97 K | 20 | 12784389 | 2.35 × 106 | 1.0 OA |
| 4 | 28607349[w] | 1025 | 1.98 K | 21 | 12525385 | 7200 | 1.1 H |
| 5 | 27866950 | 4278 | 0.86 KRE/HRE | 22 | 10743987 | 3.9 × 104 | 0.73 HRE |
| 6 | 26543059 | 821 (K), 806(H) | 2.0, 1.0 K/H | 23 | 28375889* | 7.1 × 105 | 0.6 HRE/KRE |
| 7 | 26986874[d] | 5.2 × 105 | 0.9 K, HP | 24 | 29489471* | 1.3 × 105 | 0.98 HRE |
| 8 | 17462546[ed] | 7.4 × 105 | 0.72 | 25 | 26704362 | 5853 | 0.9 SAR |
| 9 | 26777550* | 3625 | 0.81 KRE/HRE | 26 | 29158649 | 358 | 0.91 KRE |
| 10 | 26751980* | 9443 | 0.73 (K, <10 years follow up), 1.9 (>20 years follow up) | 27 | 26871792* | 3.6 × 105 | 0.84 (at 5 years follow up), 1.1 (>10 years follow up) |
| 11 | 24047870 | 1348 | 1.0 H | 28 | 28754502 | 601 | 1.97 K |
| 12 | 25778744 | 7889 | 1.14 HP | 29 | 25179456 | 850 | 0.5 OA |
| 13 | 25819581 | 1025 | 1.6 K | 30 | 21385807 | 1163 | 1.55 OA |
| 14 | 24608134 | 2125 | 1.27 K | 31 | 21282754 | 1.7 × 105 | 0.7 HRE |
| 15 | 15252092 | 8000 | 1.32 H | 32 | 24158755 | 1290 | 1.4 OA |
| 16 | doi: 10.1093/rheumatology/kez108.062 | 8066 | 1.18 H, K | 33 | 30583096 | 4182 | 1.15 K |
| 17 | 30559011* | 4907 |
0.95 HRE 1.45 HRE |
34 | 30302017* | 1.3 × 106 |
0.65 (3 years) 0.85 (7 years), HRE, KRE |
Meta-analysis of literature includes PubMed ID number of the source (PMID), the size of the study (N), the average hazard ratio in sub-cohorts (HR) for all-cause mortality in OA, K – knee generic, RKOA – knee radiographic, KSR – knee self-reported, H - hand generic, HP – hip generic, HRE – hip replacement, KRE- knee replacement, OA – osteoarthritis generic, SAR – shoulder arthroplastic, SEC – secondary, P – primary.
*The publications describing initial decrease of all-cause mortality followed by subsequent increase; [w] The publications describing the effect of decreased mobility associated with knee OA on all-cause mortality, [ed] Mutual exclusion of diseases, [d] Reductions in selected co-morbidities vs. control.